RankingsLogo

Amgen Inc.

Amgen Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Amgen Inc., formerly Applied Molecular Genetics Inc., works to make biologic medicines using living cells. It is a biotechnology company that discovers, develops, and manufactures therapeutics that help cancer patients, rheumatoid arthritis patients, and patients with autoimmune diseases.

Ticker: AMGN

Humankind Value: $294.3 B

Revenue: $27.5 B

Market Cap: $162.6 B

Badge100_2024
Positive and negative impacts of companies graphic.

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Amgen Inc. has earned a spot in our top 100, with much of its positive value coming from Healthcare R&D ($205.7 B), Pharmaceuticals ($80.2 B), and Economic Value ($7.6 B). The value associated with Healthcare R&D and Pharmaceuticals includes the impact of an estimated 5,500,000 additional years lived by people worldwide. However, there is room for improvement with respect to Greenhouse Gases (-$1.8 B) and Air Pollution (-$224.9 M). Amgen’s direct business activities are responsible for its Healthcare R&D, Pharmaceutical, Economic Value, Greenhouse Gas, and Air Pollution impacts.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings